Vernalis in £68m fundraising bid
Last updated: 10th Feb 2012 at 08:46am Pharmaceutical company Vernalis, based in Wokingham, plans to raise £68.5m via a share placing on the Stock Exchange after agreeing terms on a new joint venture. The development stage company said it would raise the capital to help fund its collaboration with US specialty pharmaceutical company Tris Pharma. Both companies have signed an exclusive licensing agreement to develop and commercialise multiple products focused on the US prescription cough and cold market. Under the [...]

